2.36
price down icon3.28%   -0.08
 
loading

Immunitybio Inc 주식(IBRX)의 최신 뉴스

pulisher
Oct 10, 2025

Will ImmunityBio Inc. rebound enough to break evenJuly 2025 Momentum & Entry and Exit Point Strategies - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Why ImmunityBio Inc. (26CA) stock is a strong analyst pick2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Will EnGene Join The Ranks Of Merck, Ferring, And ImmunityBio In Bladder Cancer Treatment? - RTTNews

Oct 09, 2025
pulisher
Oct 09, 2025

Will ImmunityBio Inc. stock outperform tech sector in 2025Quarterly Performance Summary & Precise Swing Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How ImmunityBio Inc. stock reacts to job market data2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Real time social sentiment graph for ImmunityBio Inc.2025 Pullback Review & Accurate Intraday Trading Signals - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Evaluating ImmunityBio Inc. with trendline analysis2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is ImmunityBio Inc. (26CA) stock prepared for digital transitionJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

ImmunityBio Inc. stock retracement – recovery analysis2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will ImmunityBio Inc. stock benefit from infrastructure spendingJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

ANKTIVA Reimbursement Gains and UK Approval Might Change The Case For Investing In ImmunityBio (IBRX) - Sahm

Oct 04, 2025
pulisher
Oct 03, 2025

ImmunityBio, Inc. (NASDAQ:IBRX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

What Went Wrong With ImmunityBio’s Executives Claims — and How Investors Could Still Win - TradingView

Oct 03, 2025
pulisher
Oct 03, 2025

ImmunityBio: A Small Bet Is Warranted (NASDAQ:IBRX) - Seeking Alpha

Oct 03, 2025
pulisher
Oct 03, 2025

NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com

Oct 03, 2025
pulisher
Oct 03, 2025

Short interest data insights for ImmunityBio Inc.Earnings Growth Report & Technical Pattern Recognition Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Does ImmunityBio Inc. show high probability of reboundJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What MACD and RSI say about ImmunityBio Inc.July 2025 Retail & Weekly High Return Stock Opportunities - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

ImmunityBio (IBRX): Revisiting Valuation After ANKTIVA’s Regulatory Wins and New Growth Initiatives - Sahm

Oct 03, 2025
pulisher
Oct 02, 2025

How high can ImmunityBio Inc. stock go2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Wall Street Bullish on ImmunityBio (IBRX) Since the Announcement of New Findings From QUILT-3.055 Study - MSN

Oct 02, 2025
pulisher
Oct 02, 2025

ImmunityBio’s (IBRX) ANKTIVA Shows Survival Gains in Lung Cancer Patients - MSN

Oct 02, 2025
pulisher
Oct 01, 2025

ImmunityBio, Inc. (IBRX) Reports Strong Q2 Growth, Eyes Lung Cancer and NMIBC Expansion - Insider Monkey

Oct 01, 2025
pulisher
Sep 29, 2025

What drives ImmunityBio Inc stock priceStock Liquidity Analysis & Free Trend Following Techniques - earlytimes.in

Sep 29, 2025
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
자본화:     |  볼륨(24시간):